Mintz advised the syndicate of underwriters on the deal. Viking Therapeutics, Inc. (“Viking”) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies...
You must be a Standard 1 Year member to access this content.
Mintz represented ArriVent Biopharma, Inc. on the deal. ArriVent Biopharma, Inc, a Pennsylvania-based company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, announced its $155...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. advised EIP Pharma, while Dechert LLP advised Diffusion Pharmaceuticals on the deal. Diffusion Pharmaceuticals Inc. announced a proposed...
You must be a Standard 1 Year member to access this content.
Mintz advised Princeton CarbonWorks, Inc. on the deal. Princeton CarbonWorks, Inc. obtained a victory before the U.S. District Court for the Southern District of Florida. The Connecticut-based...
You must be a Standard 1 Year member to access this content.
Mintz advised Altamira Technologies Corporation on the deal. Altamira Technologies Corporation announced its acquisition of signals intelligence mission business, Virginia Systems & Technology (VaST). The acquisition...
You must be a Standard 1 Year member to access this content.
Mintz advised Nanoco on the deal. Nanoco Group plc, a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, has announced...
You must be a Standard 1 Year member to access this content.
Mintz represented HouseWorks on the deal. HouseWorks, a leading home health care provider, announced a strategic investment from InTandem Capital, a healthcare services focused private equity...
You must be a Standard 1 Year member to access this content.
Mintz advised Lido Advisors LLC on the deal. Wealth-management firm Lido Advisors LLC, a Charlesbank Capital Partners portfolio company, announced its partnership with Colorado Financial Management (CFM)....
You must be a Standard 1 Year member to access this content.
Mintz advised Asimov on the deal. Asimov announced its $200 million fundraising aimed to scale the company’s tools and services business in biologics, cell/gene therapies, and RNA....
You must be a Standard 1 Year member to access this content.
Mintz advised QIAGEN on the deal. QIAGEN N.V. announced its $150 million completed acquisition of Verogen, a leader in the use of next-generation sequencing technologies to drive...
You must be a Standard 1 Year member to access this content.
Mintz represented Axoft on the deal. Axoft, a neurotechnology company, announced its $8 million seed round led by The Engine, a venture firm spun out of MIT...
You must be a Standard 1 Year member to access this content.
Mintz advised Charlesbank Capital Partners on the deal. ImageQuix (or the “Company”), a leading provider of workflow and ecommerce software for the high-volume photography industry, announced...
You must be a Standard 1 Year member to access this content.
